CXCL8 and central nervous system cancer: Additionally, glioma patients were significantly confirmed to possess higher circulating IL‐8 (Figure 2C) levels compared to controls, with a pooled SMD of 1.01 (95% CI: 0.17‐1.84; P = .018).